Navigation Links
ZINO Society Spurring Investments, 12 Life Sciences Companies to Vie for $50,000 ZINO Life Fund
Date:2/10/2009

SEATTLE, Feb. 10 /PRNewswire/ -- A $50,000 investment fund will be awarded to the best investment opportunity at the ZINO Society and Washington Biotechnology and Biomedical Association inaugural ZINO Life: Life Sciences Investment Forum, to be held February 24, 2009, 2:00-6:00pm at the Pan Pacific Hotel in Seattle.

Accredited investors, entrepreneurs, and business leaders are invited to attend the ZINO Life: Life Sciences Investment Forum. There will be seven minute presentations by 12 life sciences (medical devices, therapeutics, bio- technology, healthcare IT and diagnostics) entrepreneurs for the 75-100 people attending. "All entrepreneurs are competing for a $50,000 investment fund that we have put together among a few ZINO Society angel investors. Of course in addition to the fund, any of these investors or other interested investors are welcome to invest directly with any presenting company," remarked Cathi Hatch, ZINO Society Founder and CEO.

VIP speakers and panelists include Bruce Montgomery of Gilead, Bruce Carter, previously CEO of Zymogenetics, Stewart Parker, previously CEO of Targeted Genetics and Alan Smith of Fenwick &West.

                        ZINO Life Presenting Companies

    Company                 Key Contact             Website
    Amplyx Pharmaceuticals  Mitchell Mutz, Chief    www.amplyx.com
                             Science Officer
    Calcionics              Chip Jacobs, President  www.calcionics.com
                             & CEO
    Carbon Nanoprobes       Brian Ruby, CEO         www.cnprobes.com
    Clario                  Chris Wood, CEO         www.clariomedical.com
    Clarity Health Services Jeff Theil, Founder     www.clarityhealth.com
    Dimera                  R. Kent Hermsmeyer,     www.dimera.net
                             President
    Impel NeuroPharma       Michael Hite, CEO       www.impelneuropharma.com
    Innovative Pulmonary    Steven Dimmer,          www.pulmonarysolutions.net
     Solutions (IPS)         Co-founder & CEO
    Inson Medical Systems,  Tracy Klein, CEO        www.insonmed.com
     Inc.
    Longevity Surgical/     Dr. Barry H. Rabin,     www.sagetechdev.com
     SAGE                    CEO
    Oasis Diagnostics       Paul Slowey, PhD, CEO   www.4saliva.com
    Thermimage              Douglas Turnquist,      www.thermimage.com
                             President & CEO

Three of the 12 entrepreneurs will be selected as finalists to participate in Due Diligence LIVE! To help investors make investing decisions, Due Diligence LIVE! includes expert panelists asking selected follow up questions. Additionally, one of the "ZINO Zenith People's Choice" awards will determine which of the finalists will be selected to participate in Invest Northwest, an investment forum partnership between ZINO Society and WBBA to be held in March. The ZINO Life fund investors will undertake additional due diligence following ZINO Life to decide within thirty days which company will get the investment fund. The afternoon will conclude with a wine reception featuring new vintner, Wines of Substance, an awards ceremony and the opportunity for angel investors and entrepreneurs to interact one on one.

About ZINO Society

ZINO Society is a premier membership organization that connects people for positive business and social interaction, enrichment, inspiration, education and commerce. Since its inception, ZINO Society has facilitated angel funding in excess of $9.7 million for early-stage and expansion businesses. More information can be found at zinosociety.com


'/>"/>
SOURCE ZINO Society
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Weed Science Society of America Announces Winners in Annual Scientific Awards Program
2. Tips from the journals of the American Society for Microbiology
3. The American Ceramic Society releases new ACerS-NIST phase equilibria diagrams CD-ROM database
4. Proteolix Announces Positive Data From Two Ongoing Phase 2 Clinical Trials of Carfilzomib in Multiple Myeloma at the 50th Annual Meeting of the American Society of Hematology
5. Multiple Vimpat(R) (lacosamide) Studies Presented at American Epilepsy Society Annual Meeting
6. Proteolix Presents Preclinical Data for Oral Proteasome Inhibitor PR-047 at the 50th Annual Meeting of the American Society of Hematology
7. BioCryst to Present Three Posters During the 50th American Society of Hematology Annual Meeting and Exposition
8. The International Society for Stem Cell Research Releases New Guidelines to Shape Future of Stem Cell Therapy
9. Portola Data on Its Novel Syk Inhibitors and Novel Universal Factor Xa Inhibitor Antidote to be Presented at 2008 American Society of Hematology (ASH) Meeting
10. 38 Cryoablation Studies, Exhibits Presented at National Radiological Society Meeting
11. Imaging Diagnostic Systems CT Laser Mammography (CTLM(R)) System Featured at the 94th Annual Radiological Society of North America (RSNA) Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... -- China Cord Blood Corporation (NYSE: CO ... cord blood collection, laboratory testing, hematopoietic stem cell processing ... financial results for the third quarter and first nine ... Third Quarter of Fiscal 2017 Highlights ... 2017 increased by 18.6% to RMB200.9 million ($28.9 million). ...
(Date:2/24/2017)... (NASDAQ: VWR), the leading global independent provider of product and ... financial results for the fourth quarter and full year ended ... 4Q16 record quarterly net sales of $1.13 billion, up 1.6% ... 4Q16 EMEA-APAC segment net sales increased 0.4%, ... sales increased 2.5%, or down 0.9% on an organic basis, ...
(Date:2/23/2017)... RAFAEL, Calif., Feb. 23, 2017 ... U.S. dollars, except per share data, unaudited)Three Months Ended ... ChangeTotal BioMarin Revenue $   ...   22832%$ 1,117$   89026%Aldurazyme Net Product Revenue ... 906538%34823946%Naglazyme Net Product Revenue  ...
(Date:2/23/2017)... , Feb. 23, 2017  MIODx announced ... for two key immunotherapy technologies from the University ... provides a method to monitor a patient for ... PD-L1 and CTLA-4.  The second license extends the ... patient is likely to have an immune-related adverse ...
Breaking Biology Technology:
(Date:1/30/2017)... , Jan. 30, 2017   Invitae Corporation ... fastest growing genetic information companies, today announced that it ... results and provide 2017 guidance on Monday, February 13, ... call that day at 4:45 p.m. Eastern / 1:45 ... management team will briefly review financial results, guidance, and ...
(Date:1/25/2017)... , Jan. 25, 2017 The Elements ... Management (IAM) lifecycle is comprised of a comprehensive ... the purpose of maintaining digital identities and providing ... and applications. There are significant number of programs ... time to time by optimizing processes and changing ...
(Date:1/23/2017)...  The latest mobile market research from Acuity Market ... The quarterly average price of a biometric smartphone decreased ... 2016.  There are now 120 sub-$150 models on the ... just 28 a year ago at an average price ... Most , Acuity Market Intelligence Principal, "Biometric Smartphones are ...
Breaking Biology News(10 mins):